Preclinical Imaging Type and Applications , Method and Technique, Production and Prospects, Professional Global Report 2017-2024

Preclinical imaging (In-VIVO) is basically used in live animal research for drug development. Preclinical imaging is also used to observe the treatment reaction for early signs of effectiveness. The technological development of in vivo imaging offers an opportunity for reviewing disease at the molecular level in a quantitative way. In vivo imaging acts as a bridge between in vitro exploratory and in vivo clinical research which allows the direct and fast transfer of preclinical studies on animal models to clinical investigation in man.

According to a new report published by Data Bridge Market Research Global Preclinical Imaging Market By Modality(Optical Imaging Systems, Nuclear Imaging Systems, Micro-Ultrasound, Photoacoustic Imaging Systems, Micro-MRI, Micro-CT, Magnetic Particle Imaging (MPI) Systems, Photoacoustic Imaging Systems), Products (CT Imaging, Medical Devices, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical Imaging, Ultrasound Imaging),Application (Research &Development, Drug Discovery), End-User (Pharmaceutical Companies, Research Institutes, Biotechnological Companies), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

The global preclinical imaging market accounted to USD 675.0 million in 2016 growing at a CAGR of 6.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Free Market Sample Report @ http://bit.ly/2BSUBWd

Major market drivers and restraints:

• Technological Progressions

• Increasing Amount of Public-Private Initiatives

• Strict Rules Governing Preclinical Research

• Developing Markets to Offer Fresh Growing Opportunities

• Technological and Procedural Restriction

Enquire for customization in Report @ http://bit.ly/2COfkHg

Market Segmentation:

• By modality the global preclinical imaging market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Micro-Ultrasound, Photoacoustic Imaging Systems, Micro-MRI, Micro-CT, Magnetic Particle Imaging (MPI) Systems, and Photoacoustic Imaging Systems.

• Optical Imaging Systems is again bifurcated into Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, and (Optical + X-Ray)/ (Optical + Ct) Systems.

• Nuclear Imaging Systems is again bifurcated into Micro-PET Systems, Micro-Spect Systems and Trimodality (Spect/PET/CT) Systems.Micro-PET Systems is again divided into Standalone PET Systems, PET/CT Systems, and PET/MRI Systems. Micro-Spect Systems are again divided intoStandalone Spect Systems, Spect/CT Systems, and Spect/MRI Systems.

• By product the global preclinical imaging market is segmented into Computed Tomography (CT) imaging, medical devices, Magnetic Resonance Imaging (MRI)imaging, Positron Emission Tomography/ Single Photon Emission Computed Tomography (PET/SPECT)imaging, multi-modal imaging, optical imaging, and ultrasound imaging.

Read Detailed Index of full Research Study at @ http://bit.ly/2CLZmh5

• On the basis ofthe application global preclinical imaging market is segmented intoresearch & development, and drug discovery.

• On the basis of end-user the global preclinical imaging market is segmented into pharmaceutical companies, research institutes, and biotech companies.

• On the basis of geography, global preclinical imaging market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Competitive Analysis:

The global preclinical imaging market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of preclinical imaging market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors:

• Agilent Technologies,
• MILabs B.V.,
• Aspect Imaging,
• Trifoil Imaging,
• Siemens Healthcare Private Limited,
• Fujifilm Holdings Corporation,
• Bruker,
• MR Solutions,
• Capintec,
• Berthold Technologies,
• INDEC BioSystems,
• Hitachi Medical,
• LI-COR Biosciences,
• Mediso Medical Imaging Systems,
• Angstrom Advanced Inc.,
• Kubtec X-Ray,
• Miltenyi Biotec GMBH,
• Naviscan,
• PerkinElmer,
• Thermo Fisher Scientific

Find More Competitor In TOC With Profile Overview Share Growth Analysis @ http://bit.ly/2Fd3b3W

About Us :
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

This release was published on openPR.